These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 8456465)

  • 1. Evidence that an anthracycline-anti-CD8 immunoconjugate, idarubicin-anti-Ly-2.1, prolongs heart allograft survival in mice.
    Mottram PL; Pietersz GA; Smyth MJ; Purcell LJ; Clunie GJ; McKenzie IF
    Transplantation; 1993 Mar; 55(3):484-90. PubMed ID: 8456465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Idarubicin-anti-CD3: a new immunoconjugate that induces alloantigen-specific tolerance in mice.
    Mottram PL; Han WR; Murray-Segal LJ; Mandel TE; Pietersz GA; McKenzie IF
    Transplantation; 1997 Sep; 64(5):684-90. PubMed ID: 9311703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Idarubicin-145-2C11-F(ab')2 promotes peripheral tolerance and reduces chronic vascular disease in mouse cardiac allografts.
    Han WR; Murray-Segal LJ; Gershenzon A; Zhang JG; Hodder AN; Pietersz GA; Mottram PL
    Transpl Immunol; 1999 Dec; 7(4):207-13. PubMed ID: 10638833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of idarubicin monoclonal antibody treatment of first-set rejection of murine skin allografts.
    Smyth MJ; McKenzie IF; Pietersz GA
    Transplantation; 1989 Jul; 48(1):77-9. PubMed ID: 2665240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of IL-4 and IL-10 and decreased expression of IL-2 and interferon-gamma in long-surviving mouse heart allografts after brief CD4-monoclonal antibody therapy.
    Mottram PL; Han WR; Purcell LJ; McKenzie IF; Hancock WW
    Transplantation; 1995 Feb; 59(4):559-65. PubMed ID: 7878761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of peripheral tolerance in anti-CD4 treated C57BL/6 mouse heart transplants recipients.
    Han WR; Murray-Segal LJ; Mottram PL
    Transpl Immunol; 1999 Mar; 7(1):37-44. PubMed ID: 10375076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of allograft recipients with donor-specific transfusion and anti-CD154 antibody leads to deletion of alloreactive CD8+ T cells and prolonged graft survival in a CTLA4-dependent manner.
    Iwakoshi NN; Mordes JP; Markees TG; Phillips NE; Rossini AA; Greiner DL
    J Immunol; 2000 Jan; 164(1):512-21. PubMed ID: 10605049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NK cells are required for costimulatory blockade induced tolerance to vascularized allografts.
    van der Touw W; Burrell B; Lal G; Bromberg JS
    Transplantation; 2012 Sep; 94(6):575-84. PubMed ID: 22914174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of CD8 and CD4 T cells in intestinal allograft rejection: a comparison of monoclonal antibody-treated and knockout mice.
    He G; Hart J; Kim OS; Szot GL; Siegel CT; Thistlethwaite JR; Newell KA
    Transplantation; 1999 Jan; 67(1):131-7. PubMed ID: 9921809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged allograft survival in anti-CD4 antibody transgenic mice: lack of residual helper T cells compared with other CD4-deficient mice.
    Han WR; Zhan Y; Murray-Segal LJ; Brady JL; Lew AM; Mottram PL
    Transplantation; 2000 Jul; 70(1):168-74. PubMed ID: 10919596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunosuppression by anti-CD8 (Ly-2.1) MAb conjugated to idarubicin: studies in the mouse heart graft model.
    Mottram PL; Pietersz GA; Purcell LJ; Clunie GJ; McKenzie IF
    Transplant Proc; 1990 Oct; 22(5):2111-2. PubMed ID: 2120812
    [No Abstract]   [Full Text] [Related]  

  • 12. Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb.
    Lu L; Li W; Zhong C; Qian S; Fung JJ; Thomson AW; Starzl TE
    Transplantation; 1999 Sep; 68(6):747-57. PubMed ID: 10515374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolongation of allogeneic skin graft survival by injection of anti-Ly49A monoclonal antibody YE1/48.
    Yang TY; Sun Y; Langnas AN; Zhao Y
    Clin Immunol; 2003 Feb; 106(2):148-54. PubMed ID: 12672405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term allograft acceptance induced by single dose anti-leukocyte common antigen (RT7) antibody in the rat.
    Ko S; Jager MD; Tsui TY; Deiwick A; Dinkel A; Rohde F; Dahlke MH; Lauth O; Wonigeit K; Schlitt HJ
    Transplantation; 2001 Apr; 71(8):1124-31. PubMed ID: 11374414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deletion of graft reactive cells by idarubicin-anti-CD8 (Ly-2.1) immunoconjugate: studies in the mouse heart graft model.
    Mottram PL; Pietersz GA; Purcell LJ; Krauer K; Clunie GJ; McKenzie IF
    Transplant Proc; 1991 Feb; 23(1 Pt 1):499-500. PubMed ID: 1899311
    [No Abstract]   [Full Text] [Related]  

  • 16. Non-depleting anti-CD4, but not anti-CD8, antibody induces long-term survival of xenogeneic and allogeneic hearts in alpha1,3-galactosyltransferase knockout (GT-Ko) mice.
    Chong AS; Ma L; Yin D; Shen J; Blinder L; XiuLong X; Williams JW; Byrne G; Diamond LE; Logan JS
    Xenotransplantation; 2000 Nov; 7(4):275-83. PubMed ID: 11081762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LFA-1 and ICAM-1 antibody-idarubicin conjugates separately prolong murine cardiac allograft survival.
    Pietersz GA; Sandrin MS; Ling S; Li YQ; McKenzie IFC
    Transpl Immunol; 2001 Oct; 9(1):7-11. PubMed ID: 11680574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit persistent graft-reactive alloimmunity and chronic tissue remodelling.
    Orosz CG; Huang EH; Bergese SD; Sedmak DD; Birmingham DJ; Ohye RG; VanBuskirk AM
    J Heart Lung Transplant; 1997 Sep; 16(9):889-904. PubMed ID: 9322138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis.
    Shimizu K; Schönbeck U; Mach F; Libby P; Mitchell RN
    J Immunol; 2000 Sep; 165(6):3506-18. PubMed ID: 10975872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumour eradication with high-dose idarubicin-anti-Ly-2.1 with murine tumour necrosis factor-alpha in mice.
    Pietersz GA; Bogdanovski M; Li W
    Immunol Cell Biol; 1997 Jun; 75(3):253-8. PubMed ID: 9243290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.